ClinicalTrials.gg
Drug

Efalizumab clinical trials

studies test it
35
open now
0
in phase 3
8
first study started
2001

How each study uses efalizumab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
27 Oct 2003 · Raptiva · BLA 125075 (FDA, Purple Book)
European Union
20 Sept 2004 · Raptiva · EMEA/H/C/000542 (EMA; now withdrawn)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

efalizumab
25
Raptiva
15
Raptiva (efalizumab)
5

Studies by the year they started

33 studies that test it; most in 2008 (8)

Studies that test efalizumab, by start year
YearStudies
20011
20024
20034
20042
20053
20067
20074
20088

By phase

A phase 1/2 study counts in both.

Phase 1
12
Phase 2
11
Phase 3
8
Phase 4
8
No phase
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 16 · Other 19

Genentech, Inc. (10) · Merck KGaA, Darmstadt, Germany (4) · University of California, San Francisco (2) · XOMA (US) LLC (2) · Emory University (2) · Rockefeller University (1) · Oregon Health and Science University (1) · University of California, Davis (1)

Often tested with

Tested in the same studies.

Ranibizumab (2) · Abatacept (1) · Sirolimus (1) · Acitretin (1)

Studies

Open first, then newest update. How each study uses efalizumab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 35

See all 35 studies that test efalizumab →

Given beside what is tested · 1 — efalizumab is usual care or a partner of the new treatment

Codes

What other systems call efalizumab · ClinicalTrials.gg INT004515

  • MeSH (NLM) C472181efalizumabOne source NLM
  • UNII (FDA) XX2MN88N5DEFALIZUMABConfirmed FDA, NLM, Wikidata
  • RxNorm 356988Confirmed FDA, Wikidata
  • Wikidata Q418270efalizumabConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C68831EfalizumabOne source FDA
  • DrugBank DB00095One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.